Literature DB >> 8697451

Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.

P S Lin1, K C Ho, S J Yang.   

Abstract

Tirapazamine (Tira), a bioreductive agent, is highly toxic to cells under low oxygen conditions. Since active investigations of this agent are focusing on its potential as an adjunct of radiotherapy to improve overall effects on radioresistant hypoxic tumor cells, understanding its toxic mechanisms under aerobic conditions is important to the clinical application of this agent. Tira-treated V79 Chinese hamster cells were tested for cytotoxicity by colony assay and growth inhibition by the MTT assay. The survival of V79 cells after being exposed to 100 microM of Tira for 2 h was about 78% of untreated controls. The mitotic cell counts of V79 cells approached zero after 4 h treatment of Tira at 100 microM or 3 h at 300 microM. The fragmentation pattern of DNA isolated from cells 2 h after 300 microM Tira treatment showed characteristics of apoptotic cells. The induction of apoptosis by Tira was also detected by flow cytometric analysis and microscopic observation. These effects of Tira may be part of underlying toxic mechanisms to cells (including normal cells) under aerobic conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697451     DOI: 10.1016/0304-3835(96)04292-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Antitumor activities of D-glucosamine and its derivatives.

Authors:  Li Zhang; Wan-shun Liu; Bao-qin Han; Yan-fei Peng; Dong-feng Wang
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

2.  Synthesis and antitumor evaluation of novel bis-triaziquone derivatives.

Authors:  Cheng Hua Huang; Hsien-Shou Kuo; Jia-Wen Liu; Yuh-Ling Lin
Journal:  Molecules       Date:  2009-06-29       Impact factor: 4.411

3.  Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives.

Authors:  Katarzyna Błaszczak-Świątkiewicz; Joanna Sikora; Jacek Szymański; Marian Danilewicz; Elżbieta Mikiciuk-Olasik
Journal:  Tumour Biol       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.